"Jeffrey Libson enjoys a fine reputation for his work in the life sciences arena and heads the firm's practice in that area. He has a strong reputation for his work in related acquisitions and corporate governance issues." - Chambers USA 2015
Jeffrey P. Libson is a Corporate and Securities partner in the Berwyn office of Pepper Hamilton LLP. He is the head of the firm’s life sciences practice. Mr. Libson’s practice is devoted primarily to the areas of securities law, venture financing, mergers and acquisitions, corporate governance and the commercialization, licensing and acquisition of intellectual property.
He represents a number of publicly traded and closely held life science companies in ongoing representations as outside general counsel. He also represents a number of nonprofit entities that support the life sciences industry.
Within the securities and venture financing practice areas, Mr. Libson has represented investment banks and issuers in public offerings (including initial public offerings) and private placements of equity and debt securities, and has represented both funding sources and companies in venture financing transactions.
Within the mergers and acquisitions practice area, Mr. Libson has represented buyers, sellers and investors in numerous acquisition, disposition and combination transactions, affecting both public and private companies. Company industries include biotech, diagnostics, pharmaceutical, health care and e health, and communications, among others.
Within the intellectual property practice area, Mr. Libson has represented numerous companies, including pharmaceutical companies, biotechnology companies, consumer products companies, computer software developers and R&D contractors, in corporate partnering transactions, the acquisition and licensing of patents, trademarks, copyrights and trade secrets, and in the development of new products and technologies.